HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes.

AbstractBACKGROUND:
Altered tumor suppressor p53 and/or CDKN2A as well as Ras genes are frequently found in primary and metastatic melanomas. These alterations were found to be responsible for acquisition of invasive and metastatic potential through their defective regulatory control of metalloproteinases and urokinase genes.
METHODOLOGY/PRINCIPAL FINDINGS:
Using primary human melanoma M10 cells with altered p53, CDKN2A and N-Ras genes, we found that inhibition of the proprotein convertases (PCs), enzymes involved in the proteolytic activation of various cancer-related protein precursors resulted in significantly reduced invasiveness. Analysis of M10 cells and their gastric and lymph node derived metastatic cells revealed the presence of all the PCs found in the secretory pathway. Expression of the general PCs inhibitor alpha1-PDX in these cells in a stable manner (M10/PDX) had no effect on the mRNA expression levels of these PCs. Whereas, in vitro digestion assays and cell transfection experiments, revealed that M10/PDX cells display reduced PCs activity and are unable to process the PCs substrates proIGF-1R and proPDGF-A. These cells showed reduced migration and invasion that paralleled decreased gelatinase MMP-2 activity and increased expression and secretion of tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2. Furthermore, these cells showed decreased levels of urokinase-type plasminogen activator receptor (uPAR) and increased levels of plasminogen activator inhibitor-1 (PAI-1).
CONCLUSIONS:
Taken together, these data suggest that inhibition of PCs activity results in decreased invasiveness of primary human melanoma cells despite their altered p53, CDKN2A and N-Ras genes, suggesting that PCs may serve as novel therapeutic targets in melanoma.
AuthorsClaude Lalou, Nathalie Scamuffa, Samia Mourah, Francois Plassa, Marie-Pierre Podgorniak, Nadem Soufir, Nicolas Dumaz, Fabien Calvo, Nicole Basset-Seguin, Abdel-Majid Khatib
JournalPloS one (PLoS One) Vol. 5 Issue 4 Pg. e9992 (Apr 09 2010) ISSN: 1932-6203 [Electronic] United States
PMID20404912 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Matrix Metalloproteinase Inhibitors
  • alpha 1-Antitrypsin
  • alpha 1-antitrypsin Portland
  • Proprotein Convertases
  • Matrix Metalloproteinase 2
Topics
  • Genes, p16
  • Genes, p53 (genetics)
  • Genes, ras (genetics)
  • Humans
  • Lymph Nodes (pathology)
  • Matrix Metalloproteinase 2 (metabolism)
  • Matrix Metalloproteinase Inhibitors
  • Melanoma (enzymology, genetics, pathology)
  • Neoplasm Invasiveness
  • Proprotein Convertases (antagonists & inhibitors)
  • Stomach (pathology)
  • Tumor Cells, Cultured
  • alpha 1-Antitrypsin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: